List of findings

Use the filters on the left to narrow down the list of findings, or use "Browse by keyword" on the right to locate a specific finding.

In South-Eastern Europe, and Western and Central Europe, amphetamine-type stimulants (ATS) use and health harm remain mainly linked to amphetamine and are relatively low compared to other regions.Amphetamines are the third most common stimulant drugs group in Europe after cocaine and “ecstasy”.…
Australia and New Zealand have the highest global annual prevalence of use of "ecstasy", where it is mostly used in capsule and crystal form.In Australia, the use and availability of "ecstasy" declined during the COVID-19 pandemic but have started to increase again in 2023 (while not yet reaching…
“Ecstasy” use remains concentrated in Europe (mainly Western and Central Europe)Use is significantly higher in Western and Central Europe than in Eastern and South-Eastern Europe, both in terms of prevalence (1.2 per cent vs. 0.4 per cent) and number of users (nearly 4 million versus less than 800,…
As intensive methamphetamine use has increased in both Australia and New Zealand, associated health harms have also increased.In Australia, hospitalizations and the number of people in drug-related treatment related to methamphetamine use have increased over the long-term, although recent data…
Seizures of methamphetamine have shown a clear upward trend in Oceania over the last decade. Seizures of methamphetamine in Oceania reached a new record high in 2024, mainly driven by rising seizures reported from Australia and New Zealand. At the same time, the…
In Australia, past-year methamphetamine use has declined since 2004, but among people who still used the drug, there are signs of increases in intensive use patterns.A similar trend is observed in New Zealand, where the police characterize the methamphetamine market as saturated. Intensive use of…
Seizures of amphetamine-type substances (ATS) in Europe are rising, with methamphetamine increasingly overtaking amphetamine.Seizures of ATS have increased strongly in Europe over the last decade, with growth reported for methamphetamine, amphetamine, “ecstasy” and non-specified and other ATS (…